Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis.
about
Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.Characterization of Toxoplasma gondii glyoxalase 1 and evaluation of inhibitory effects of curcumin on the enzyme and parasite culturesA Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).Drugs in development for toxoplasmosis: advances, challenges, and current status.
P2860
Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis.
@en
type
label
Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis.
@en
prefLabel
Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis.
@en
P2093
P2860
P50
P356
P1476
Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis.
@en
P2093
Agata Paneth
Katarzyna Dzitko
Lidia Węglińska
P2860
P304
P356
10.1128/AAC.03832-14
P407
P577
2014-10-06T00:00:00Z